HOME › DRUGS › PEGASPARGASE
ACTIVE SUBSTANCE / INN

PEGASPARGASE

Brand name(s): Oncaspar, ONCASPAR
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Precursor Cell Lymphoblastic Leukemia-Lymphoma
BLA103411
ACTIVE SUBSTANCE
Pegaspargase
REGULATORS
FDA · EMA
SPONSORS / MAH
SIGMA TAU, Les Laboratoires Servier
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ONCASPARBLA103411SIGMA TAUPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
OncasparLes Laboratoires ServierAuthorised14/01/2016Precursor Cell Lymphoblastic Leukemia-Lymphoma

FULL INTELLIGENCE ON PEGASPARGASE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →